OSAKA -- Shionogi & Co. will release what it calls the world's first one-day treatment for influenza in Japan as early as 2018.
Unlike conventional offerings, the new drug prevents the flu virus from propagating. It inhibits the activity of enzymes that aid the propagation of viruses that enter the body through the throat or nose. The drug is taken orally.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.